Reuters logo
4 个月前
BRIEF-Seres Therapeutics Inc Q1 loss per share $0.63
2017年5月4日 / 中午11点41分 / 4 个月前

BRIEF-Seres Therapeutics Inc Q1 loss per share $0.63

May 4 (Reuters) - Seres Therapeutics Inc

* Seres Therapeutics reports first quarter 2017 financial results and provides update on operational progress

* Seres Therapeutics Inc - Q1 loss per share $0.63

* Qtrly total revenue $3.02 million versus $2.71 million

* Q1 earnings per share view $-0.66, revenue view $2.3 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below